Search Results

Displaying Results 1-3 of 3 "'BPMC'"
Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.
$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger: VRNA, <em>BPMC,</em> DALN, and RGLD

Jul 18, 2025, 17:32 ET $HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger: VRNA, BPMC, DALN, and RGLD

BPMC) related to its sale to Sanofi, S.A. Under the terms of the proposed transaction, Sanofi will pay $129.00 per

More news about: Monteverde & Associates PC

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates <em>BPMC,</em> SAGE, SOL on Behalf of Shareholders

Jun 23, 2025, 13:30 ET SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BPMC, SAGE, SOL on Behalf of Shareholders

multimedia:https://www.prnewswire.com/news-releases/shareholder-investigation-halper-sadeh-llc-investigates-bpmc-sage-sol-on-behalf-of-shareholders-302488394.html

More news about: Halper Sadeh LLP

Blueprint Medicines Announces Data Reinforcing Sustained Clinical Efficacy and Well-Tolerated Safety Profile of Long-Term AYVAKIT®/AYVAKYT® (avapritinib) Treatment at 2025 EHA and EAACI Congresses

Jun 12, 2025, 18:01 ET Blueprint Medicines Announces Data Reinforcing Sustained Clinical Efficacy and Well-Tolerated Safety Profile of Long-Term AYVAKIT®/AYVAKYT® (avapritinib) Treatment at 2025 EHA and EAACI Congresses

Mass., June 12, 2025 /PRNewswire/ -- Blueprint Medicines Corporation (Nasdaq: BPMC) today announced data presentations reflecting over a decade of collaboration with clinical experts and patient advocates to transform the treatment

More news about: Blueprint Medicines Corporation

Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.